MDGL

MADRIGAL PHARMACEUTICALS INC

MDGL·558868105·US·Common Stock·Healthcare - Biotechnology-Activist

MDGL (MADRIGAL PHARMACEUTICALS INC) is held by 197 institutional investors as of Q2 2026. Largest holders: BAKER BROS. ADVISORS LP ($1.2B), RTW INVESTMENTS, LP ($1.1B), Avoro Capital Advisors LLC ($984.4M). Net institutional sentiment: Mixed.

197
Holders
(14 Elite)
$9.9B
Total Value
48% (198)
Consensus
96 buying - 102 selling
13F: Insider & Congress: Updated regularly
MDGL

Smart Money Verdict

View all
Loading verdict
Held by 197 funds
14 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 20, 2026 · Activists Jul 29, 2026 · Congress none

InsiderKTKelley Shannon TSell $342KAug 17, 2026
InsiderRCREED JOHN CVest 647 shAug 15, 2026
ActivistBlackRock, Inc.BlackRock, Inc.4.6%Jul 29, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
2.1M(+0.1%)$1.2B5.8%+223.38%
62
Unchanged
2M$1.1B9.1%+103.07%
0
Increased
1.8M(+0.8%)$984.4M8.8%+232.85%
63
Decreased
1.2M(-23.0%)$644.8M0.0%+60.69%
0
Increased
835,668(+1.0%)$448.7M0.0%+26.21%
31
Increased
825,714(+18.8%)$443.4M0.1%+16.96%
37
Decreased
781,731(-7.1%)$419.8M0.0%+26.54%
0
Decreased
527,057(-13.5%)$283M0.0%+121.56%
0
Increased
507,233(+11.8%)$272.4M0.0%+25.73%
34
Increased
401,708(+241.1%)$215.7M0.0%+15.31%
49
Decreased
374,880(-17.8%)$201.3M0.0%+184.28%
0
Decreased
356,201(-30.4%)$191.3M0.0%+54.80%
0
Decreased
324,123(-4.8%)$174M0.5%+62.68%
0
Decreased
301,435(-8.5%)$161.9M0.0%+41.38%
0
Decreased
246,280(-11.2%)$132.2M0.0%+42.39%
0
Decreased
244,274(-15.6%)$131.2M0.3%+66.14%
0
Increased
231,205(+135.5%)$124.1M0.0%+8.91%
49
Increased
210,205(+14.5%)$112.9M0.2%+109.45%
41
Increased
192,896(+3.0%)$103.5M0.1%+128.84%
31
Increased
191,541(+434.5%)$102.8M0.0%+3.75%
48

Showing 1-20 of 211

1 / 11
MDGLMDGLMADRIGAL PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used